New trend in unapproved stem cell therapy led to sepsis in some patients

Several individuals in Nebraska developed severe infections after receiving unapproved cell-based therapies said to include exosomes, state health officials said.

These patients — fewer than five — became seriously ill, with some developing sepsis, Leah Bucco-White, a spokesperson with the Nebraska Department of Health and Human Services, told MedPage Today via email.

All were given an exosome product that was derived from C-sectioned placentas, according to a health alert sent by the state to clinicians. MedPage Today has previously reported on a growing trend of hospitals implementing placenta donation programs and potential links to unapproved stem cell products.

Read full article at